In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to results of the first whole-genome study of IBD in African Americans. ...
Feb 19, 2021
0
2
Alzheimer's disease and related dementias (ADRD) are degenerative brain diseases that affect over 5.8 million people in the U.S. Rates of ADRD are higher among Black and Latinx individuals compared to non-Latinx white individuals. ...
Nov 6, 2020
0
35
A new study has found an association between low average levels of vitamin D and high numbers of COVID-19 cases and mortality rates across 20 European countries.
May 7, 2020
3
24834
Few areas of science have seen such a dramatic development in the last decade as genomics. It is now possible to read the genomes of millions of people in so-called genome-wide association studies. These studies have identified ...
Oct 15, 2019
0
2
A new study, published in Antimicrobial Agents and Chemotherapy conducted by a University of Liverpool led research consortium, has helped develop a new treatment option for some multi-drug resistant (MDR) infections.
May 29, 2019
0
1
(HealthDay)—Can't quite spit out the right, uh, word at times? A new study helps explain why.
May 28, 2018
0
10
Pain serves as a valuable warning signal, but when it becomes chronic, pain should be considered as a real disease. An international team including research scientists from the CNRS and INSERM1 has identified and controlled ...
Dec 22, 2016
0
1
SSRI antidepressants (Selective Serotonin Reuptake Inhibitors, the best known being Prozactm) are amongst the most commonly taken medicines. However, there seems to be no way of knowing in advance whether or not SSRIs will ...
Sep 20, 2016
0
11
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events, a group of European researchers has found. Writing in the Lancet, the team say that immediate self-treatment ...
May 18, 2016
0
242
Swiss pharmaceutical group Roche hopes to obtain fast-track US approval for a rapid diagnostic test for Ebola, its director general said in an interview published Sunday, amid the worst-ever outbreak of the killer disease.
Oct 26, 2014
0
0
